Browsing by Author Waring, Paul

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2004Cerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report.Yip, Desmond; Beshay, Victoria; Chong, Guan; Goldstein, David; Hughes, Brett G; Waring, Paul; MedicineCerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report., BMC Cancer, vol.4,(1),2004,pp 74-80
2015Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testingCooper, Wendy Anne; Gill, Anthony; Pavlakis, Nick; Amanuel, Benhur; Christie, Michael; Diakos, Connie; Lum, Trina; McNeil, Catriona; Millward, Michael; Morey, Adrienne; O'Toole, Sandra; Peverall, Joanne; Selinger, Christina; Tran, Yen; Van Vliet, Chris; Waring, Paul; Central Clinical School: Medicine; Northern Clinical School: Pathology; Northern Clinical School: MedicineEquivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing, Histopathology, vol.67, 5, 2015,pp 654-663
2006Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.Au, Wendy; Henderson, Beric; Bekessy, A.; Brinkworth, R.; Brown, M A; Chenevix-Trench, Georgia; Couch, F J; Diez, O.; Goldgar, D; Healey, Stephen E; Hinson, S.; Hopper, J; Izatt, L.; Jenkins, M; Lindeman, Geoffrey J.; Lovelock, Paul K.; Renard, Helene; Solomon, E; Southey, Melissa C.; Spurdle, Amanda B.; Sum, Eleanor Y M; Tavtigian, S V; Tesoriero, A.; Visvader, Jane E; Waring, Paul; Wong, E. M.; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteGenetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants., Journal of Medical Genetics 2005, vol.43,(1),2006,pp 74-83
2006Histopathological features of breast cancer in carriers of ATM gene variants.Balleine, Rosemary; Bilous, Michael; Byth Wilson, Karen; Kirk, Judy; Provan, Pamela; Farshid, Gelareh; KConFab, Consortium; Murali, R; Thorne, Heather; Waring, Paul; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteHistopathological features of breast cancer in carriers of ATM gene variants., Histopathology, vol.49,(5),2006,pp 523-532
2016ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumoursGebski, Val; Khasraw, Mustafa; Pavlakis, Nick; Thavaneswaran, Subotheni; Wilson, Kate; Chantrill, Lorraine A; Day, Fiona; Desai, Jayesh; Elez, Elena; et al, Various; Jefford, Michael; Nott, Louise M; Segelov, Eva; Underhill, Craig; Waring, Paul; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours, BMC Cancer, vol.16, 1, 2016,pp 1-8
2006Morphology of Breast Cancer as a Means of Triage of Patients for BRCA1 Genetic TestingBalleine, Rosemary; Cummings, M; Farshid, G; The Kathleen Cunningham Consortium for Research into Familial Breast Cancer, .; Waring, Paul; Western Clinical School: Medicine (Westmead)Morphology of Breast Cancer as a Means of Triage of Patients for BRCA1 Genetic Testing, American Journal Of Surgical Pathology, vol.30,(11),2006,pp 1357-1366
2016Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM StudyGebski, Val; Khasraw, Mustafa; Pavlakis, Nick; Robledo, Kristy; Simes, Robert John; Thavaneswaran, Subotheni; Wilson, Kate; Chantrill, Lorraine A; Desai, Jayesh; Elez, Elena; et al, Various; Karapetis, Christos (Chris); Lunke, Sebastian; Nott, Louise M; Segelov, Eva; Underhill, Craig; Waring, Paul; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; School of Molecular Bioscience (SMB)Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2258-2264
2015Ubiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegalyHenneicke, Holger; Bywater, Megan; et al, Various; Hare, Lauren; Kinross, Kathryn; Kleinschmidt, Margarete; Malaterre, Jordane; Mangiafico, S; Montgomery, Karen; Poulton, Ingrid; Vrahnas, Christina; Waring, Paul; Concord Clinical School: ANZAC Research InstituteUbiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly, The FASEB Journal, vol.29, 4, 2015,pp 1426-1434